Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Browse
Companies
The NIH supports and conducts basic, clinical, and translational medical research, and investigates the causes, treatments, and cures for both common and rare diseases. More
WORLDiscoveries™ is the new Business Development arm of London’s extensive Research network and the bridge between local invention and global industry. More
LAWSON HEALTH RESEARCH INSTITUTE is one of Canada's largest hospital-based research institutes. More
The University of Edinburgh has an international reputation for world-class research in medicine and biotechnology. More
Spanish public research organisation with 126 centres covering all knowledge areas and highly active in collaborating with the industry. More
LBN was established in June 2000, providing the first co-ordinated approach to biotechnology in London. With over 2000 members, LBN is now one of the largest biotechnology networks in Europe. More
The IRC Network Biotechnology Thematic Group's goal is to contribute to the promotion of innovation in the European Biotechnology sector through technology transfer. More
QMUL aims to create social and economic benefits for society by developing a culture of innovation and enterprise that will facilitate the commercial exploitation of academic research and technology. More
Proteome Sciences is a global leader in applied proteomics applying high sensitivity proprietary technologies to detect differentially expressed proteins in diseases. More
Good Biotech Corporation (GBC) is a leading producer of industrial scale high-purity polyclonal IgY(-Fc) antibodies from duck egg yolk, offering a wide range of biotechnology applications. More
Your selection
Browse By
- Therapeutic target
- Adoptive immunotherapy
- Amyloidosis
- Autoimmune disease (non-specific)
- Chronic fatigue syndrome
- Chronic granulomatous disease
- Chronic immunosuppression
- Gout
- Graft versus host disease
- HIV/AIDS
- Immune disorder (non-specific)
- Immune thrombocytopenic purpura
- Immunomodulation
- Immunostimulation
- Immunosuppression
- Lupus erythematosis
- Myalgic encephalomyelitis
- Myasthenia gravis
- Neoplastic disease
- Organ transplant rejection
- Rheumatoid arthritis
- Servere combined immunodeficency
- Sjogren's syndrome
- Systemic sclerosis
- Transplant rejection
- Xenotransplantation
- Geographic location
- Africa
- Asia
- Australia/New Zealand
- Central America
- Europe
- Near & Far East
- North America
- South America
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us